Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1365553 | Bioorganic & Medicinal Chemistry Letters | 2007 | 4 Pages |
Abstract
Continuing with our search of aliphatic dicationic derivatives as I2-IBS ligands and looking at Amiloride, a known ligand of I2-IBS, we have incorporated the guanidinocarbonyl moiety into our aliphatic compounds with the intention of improving the binding to I2-IBS. Thus, we present the different approaches to the preparation and pharmacological evaluation (in human brain tissue) as I2-IBS ligands of a new series of aliphatic derivatives incorporating the guanidinocarbonyl group and with different chain length (n = 8–12, and 14 methylene groups).
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Jonathan Corcoran, Fernando Rodriguez, Isabel Rozas, J. Javier Meana, Luis F. Callado,